Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

chimeric antigen receptor, immunology
SARS-CoV-2 Isn’t Going Away, Experts Predict
SARS-CoV-2 Isn’t Going Away, Experts Predict
David Adam | Jan 25, 2021
As politicians try to schedule an end to the pandemic, scientists say the virus will stick around as an endemic disease similar to the common cold.
Moderna Developing Booster Shot for New Virus Variant B.1.351
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
A Tweak to Immune Cells Reverses Aging in Mice
A Tweak to Immune Cells Reverses Aging in Mice
Abby Olena | Jan 20, 2021
Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.
Harnessing Single-cell Multi-omic Energy States for Integrated Cancer Biology
Harnessing Single-cell Multi-omic Energy States for Integrated Cancer Biology
The Scientist Creative Services Team | Jan 20, 2021
Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.
Past SARS-CoV-2 Infection Mostly Protects Survivors
Past SARS-CoV-2 Infection Mostly Protects Survivors
Max Kozlov | Jan 14, 2021
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
Beauty Is More Than Skin Deep: 3D Imaging from Micro to Macro
Beauty Is More Than Skin Deep: 3D Imaging from Micro to Macro
The Scientist Creative Services Team | Jan 12, 2021
Lai Guan Ng will discuss how whole-skin imaging advances skin immunity research.
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
Asher Jones | Jan 11, 2021
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
Severe Allergic Reactions to COVID-19 Vaccine Are Rare: CDC
Severe Allergic Reactions to COVID-19 Vaccine Are Rare: CDC
Lisa Winter | Jan 7, 2021
The majority of people experiencing anaphylaxis had a history of allergic reactions, a report by the agency finds.